CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 1 other location
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...
Phase 1
Salt Lake City, Utah, United States and 16 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Salt Lake City, Utah, United States and 117 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Ogden, Utah, United States of America and 226 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Ogden, Utah, United States and 145 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Salt Lake City, Utah, United States and 50 other locations
to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 55 other locations
The purpose of this study is to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combinati ...
Phase 1, Phase 2
West Valley City, Utah, United States and 3 other locations
be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer. Dose expansion will ...
Phase 1
Salt Lake City, Utah, United States and 1 other location
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...
Phase 2
Salt Lake City, Utah, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal